Company / Current Assets
ImageneBio, Inc. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$140.3M
FY2025
5-year range
$127.2M / $236.5M
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 5 years, ranging from $127M in FY2024 to $237M in FY2021.
Based on SEC 10-K filings.
$140M in FY2025 with a 3-year CAGR of -4.3%.
Declined from $179M to $140M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -4.3%, indicating a declining trend.
- In FY2025, current assets increased 10.3% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $140.3M | +10.3% |
| FY2024 | $127.2M | -28.8% |
| FY2023 | $178.7M | +11.7% |
| FY2022 | $160.0M | -32.3% |
| FY2021 | $236.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026